Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test
Go back to Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test| Amarantus Bioscience Holdings, Inc. Common stock (AMEX: AMBS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $1.53 | |||
| Open | $0.00 | 52 Week Low | $0.01 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-0.04 | |||
| Volume | 960,957 | |||||
| (NASDAQ: AVDX) | Delayed: 10.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.00 | 52 Week High | $0.72 | |||
| Open | $10.00 | 52 Week Low | $0.11 | |||
| Day High | $10.00 | P/E | N/A | |||
| Day Low | $10.00 | EPS | $0.00 | |||
| Volume | 10,558 | |||||
